A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who developed it. Loading audio...

The drug, known as KCL-HO-1i, works by disarming a defence mechanism that tumours use to protect themselves.

Early tests on mice found the drug even helped chemotherapy-resistant tumours to respond to treatment.

It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a "valuable companion drug" to chemotherapy, helping patients to avoid more aggressive treatments.

Chemotherapy is used to treat many kinds of cancer and works by disrupting the way cancer cells grow and divide.

However, in some patients it is not as effective as it should be because the body's own immune cells can act as a barrier

See Full Page